ICON to Acquire MediMedia Pharma Solutions

ICON plc has agreed to acquire MediMedia Pharma Solutions for $120 million in cash, adding expertise in scientific communications and market access to ICON’s Commercialization and Outcomes services. Owned by Vestar Capital Partners, MediMedia supports development launches and in-market products spanning numerous therapeutic classes.

Ciaran Murray, ICON chief executive officer, said, “The need to demonstrate and communicate the value of new medicines is an important global healthcare trend. Through ICON’s market leading commercialization and outcomes group we are supporting our customers to maximize the value of their new drugs. Our acquisition of MediMedia Pharma Solutions deepens the expertise of this group and brings us outstanding scientific and medical communications capabilities.”

Tim Search, president of MediMedia Pharma Solutions, said,“The combination of the commercial, scientific, and market access expertise of MediMedia Pharma Solutions and ICON creates an unparalleled offering that can inform product investment decisions and establish and communicate product value. With the shift to evidence-based medicine and value-based pricing, we are excited about the expanded expertise and capabilities our relationship with ICON brings to our combined customers.”